|
27 desembre 2016 |
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
|
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
1 juny 2018 |
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase |
|
|
|
5 juny 2018 |
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
juny 2019 |
Andrògen – Independència en el cáncer de próstata |
Espuña Navarro, Laura
|
|
|
juliol 2023 |
Desenvolupament d’un sistema d’entrega de fà rmacs proteics antitumorals produït en Escherichia coli basat en la proteïna majorità ria de la volta eucariota |
Casadevall Monells, Arnau
|
|
|
juliol 2023 |
Developing a new method for nanoparticle characterization and cell trafficking using expansion microscopy as high- resolution fluorescent microscopy technique |
Castells Colldeforn, Pau
|
|
|
setembre 2018 |
Disseny i caracterització de complexos de ruteni amb potencial activitat anticancerÃgena |
Roldán Galán, Lidia
|
|
|
setembre 2017 |
Estudi de la inhibició de la sintasa d’à cids grassos (FASN) per revertir la resistència al gefitinib en adenocarcinoma de pulmó |
Trias Alguacil, Maria del Mar
|
|
|
setembre 2017 |
Estudi de l’activitat biològica de compostos organometà l•lics com agents antitumorals vehiculitzats amb anà legs de la Bombesina |
Romero Pérez, Inés
|
|
|
|
Generation of new cytotoxic human ribonuclease variants directed to the nucleus |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ruiz MartÃnez, Santiago
; Tubert Juhé, Pere
; Escribano, Diego
; Ribó i Panosa, Marc
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
7 setembre 2012 |
Generation of new cytotoxic human ribonuclease variants directed to the nucleus |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ruiz MartÃnez, Santiago
; Tubert Juhé, Pere
; Escribano, Diego
; Ribó i Panosa, Marc
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
2015 |
An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies |
Gandioso, Albert
; Shaili, Evyenia
; Massaguer i Vall-llovera, Anna
; Artigas, Gerard
; González-Cantó, Alejandro
; Woods, Julie A.
; Sadler, Evyenia
; Marchán, Vicente
|
|
|
|
An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies |
Gandioso, Albert
; Shaili, Evyenia
; Massaguer i Vall-llovera, Anna
; Artigas, Gerard
; González-Cantó, Alejandro
; Woods, Julie A.
; Sadler, Evyenia
; Marchán, Vicente
|
|
|
|
An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies |
Gandioso, Albert
; Shaili, Evyenia
; Massaguer i Vall-llovera, Anna
; Artigas, Gerard
; González-Cantó, Alejandro
; Woods, Julie A.
; Sadler, Evyenia
; Marchán, Vicente
|
|
|
1 juny 2018 |
An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies |
|
|
|
5 juny 2018 |
An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies |
Gandioso, Albert
; Shaili, Evyenia
; Massaguer i Vall-llovera, Anna
; Artigas, Gerard
; González-Cantó, Alejandro
; Woods, Julie A.
; Sadler, Evyenia
; Marchán, Vicente
|
|
|
setembre 2018 |
Ligandos autocrinos en la resistencia a erlotinib del cáncer pancreático |
Gámez GarcÃa-Cervigón, Andrés
|
|
|
novembre 2023 |
Prexasertib and Olaparib: overcoming PARPi resistance in high-grade serous ovarian carcinoma |
Ramirez de Cartagena i Fuentes, Mariona
|
|
|
juny 2018 |
Proteïnes que de forma natural maten selectivament cèl·lules tumorals |
Obiols Hurtado, Mireia
|
|
|
2008 |
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Colomer, Ramon
; Llorens Duran, Rafael de
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
|
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Colomer, Ramon
; Llorens Duran, Rafael de
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
|
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Colomer, Ramon
; Llorens Duran, Rafael de
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
1 juny 2018 |
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling |
|
